Rank | Gene Set | Z-score |
---|---|---|
1 | NIK/NF-kappaB signaling (GO:0038061) | 7.81873606 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.73008729 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.28288930 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.28288930 |
5 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.64280365 |
6 | regulation of T cell tolerance induction (GO:0002664) | 5.58843226 |
7 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.56183787 |
8 | regulation of activation of Janus kinase activity (GO:0010533) | 5.19770744 |
9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.16297349 |
10 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.14484426 |
11 | regulation of alpha-beta T cell proliferation (GO:0046640) | 5.06451564 |
12 | regulation of RIG-I signaling pathway (GO:0039535) | 5.05986094 |
13 | myeloid dendritic cell differentiation (GO:0043011) | 5.02035603 |
14 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.95473253 |
15 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.90944570 |
16 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.86420968 |
17 | positive regulation of interleukin-2 production (GO:0032743) | 4.75038938 |
18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.66104154 |
19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.65079212 |
20 | cellular response to type I interferon (GO:0071357) | 4.63467265 |
21 | type I interferon signaling pathway (GO:0060337) | 4.63467265 |
22 | response to type I interferon (GO:0034340) | 4.59559849 |
23 | myeloid dendritic cell activation (GO:0001773) | 4.58159446 |
24 | * negative thymic T cell selection (GO:0045060) | 4.49034337 |
25 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.45986030 |
26 | regulation of memory T cell differentiation (GO:0043380) | 4.36351174 |
27 | * positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.35848773 |
28 | growth hormone receptor signaling pathway (GO:0060396) | 4.35678705 |
29 | * negative T cell selection (GO:0043383) | 4.31751445 |
30 | T-helper 1 type immune response (GO:0042088) | 4.30544833 |
31 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29214451 |
32 | negative regulation of T cell mediated immunity (GO:0002710) | 4.29108033 |
33 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 4.27388634 |
34 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 4.24232696 |
35 | regulation of T-helper cell differentiation (GO:0045622) | 4.23986426 |
36 | regulation of tolerance induction (GO:0002643) | 4.23302835 |
37 | neutrophil activation involved in immune response (GO:0002283) | 4.23198385 |
38 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.22419587 |
39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.18158554 |
40 | positive regulation of type 2 immune response (GO:0002830) | 4.16197001 |
41 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.16072909 |
42 | natural killer cell mediated immunity (GO:0002228) | 4.16072909 |
43 | * positive regulation of interleukin-12 production (GO:0032735) | 4.12813837 |
44 | neutrophil activation (GO:0042119) | 4.10842781 |
45 | negative regulation of interleukin-12 production (GO:0032695) | 4.07858329 |
46 | tolerance induction (GO:0002507) | 4.06710756 |
47 | T-helper cell differentiation (GO:0042093) | 4.01689137 |
48 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.01689137 |
49 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.97805638 |
50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.95224375 |
51 | positive regulation of T cell cytokine production (GO:0002726) | 3.94657406 |
52 | regulation of immunoglobulin secretion (GO:0051023) | 3.93235940 |
53 | T cell migration (GO:0072678) | 3.91778373 |
54 | granulocyte activation (GO:0036230) | 3.89294304 |
55 | cellular response to zinc ion (GO:0071294) | 3.89000673 |
56 | natural killer cell activation (GO:0030101) | 3.87815706 |
57 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.87694119 |
58 | natural killer cell differentiation (GO:0001779) | 3.82320893 |
59 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.79158544 |
60 | immunoglobulin mediated immune response (GO:0016064) | 3.77978489 |
61 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.77703365 |
62 | regulation of chronic inflammatory response (GO:0002676) | 3.77138058 |
63 | defense response to protozoan (GO:0042832) | 3.76506008 |
64 | cellular response to growth hormone stimulus (GO:0071378) | 3.73222853 |
65 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.72673760 |
66 | negative regulation of cell killing (GO:0031342) | 3.72673760 |
67 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.72346053 |
68 | response to muramyl dipeptide (GO:0032495) | 3.65092378 |
69 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.64768773 |
70 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.63951030 |
71 | modulation by symbiont of host immune response (GO:0052553) | 3.63951030 |
72 | positive regulation by symbiont of host defense response (GO:0052509) | 3.63951030 |
73 | modulation by symbiont of host defense response (GO:0052031) | 3.63951030 |
74 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.63951030 |
75 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.63951030 |
76 | T cell costimulation (GO:0031295) | 3.61916499 |
77 | positive regulation of activated T cell proliferation (GO:0042104) | 3.60941892 |
78 | positive thymic T cell selection (GO:0045059) | 3.59889212 |
79 | cellular response to interleukin-15 (GO:0071350) | 3.59791828 |
80 | natural killer cell activation involved in immune response (GO:0002323) | 3.59487323 |
81 | positive regulation of interleukin-17 production (GO:0032740) | 3.58111123 |
82 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.57100857 |
83 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.56963756 |
84 | response to interleukin-15 (GO:0070672) | 3.56742449 |
85 | lymphocyte costimulation (GO:0031294) | 3.54493846 |
86 | positive regulation of interferon-alpha production (GO:0032727) | 3.54434811 |
87 | T cell differentiation involved in immune response (GO:0002292) | 3.53835439 |
88 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.53835439 |
89 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.53835439 |
90 | response to protozoan (GO:0001562) | 3.52620771 |
91 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.52265614 |
92 | regulation of T-helper 1 type immune response (GO:0002825) | 3.52087172 |
93 | * T cell selection (GO:0045058) | 3.51998593 |
94 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.46339317 |
95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.45847546 |
96 | positive regulation of tolerance induction (GO:0002645) | 3.45597889 |
97 | regulation of regulatory T cell differentiation (GO:0045589) | 3.45433983 |
98 | positive regulation of isotype switching (GO:0045830) | 3.45087403 |
99 | B cell proliferation (GO:0042100) | 3.44927333 |
100 | cellular response to interferon-beta (GO:0035458) | 3.44256240 |
101 | * thymic T cell selection (GO:0045061) | 3.40571494 |
102 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 3.38904276 |
103 | regulation of natural killer cell differentiation (GO:0032823) | 3.37775062 |
104 | regulation of gamma-delta T cell activation (GO:0046643) | 3.36929767 |
105 | leukocyte aggregation (GO:0070486) | 3.36151882 |
106 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.35883645 |
107 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.35883645 |
108 | negative regulation of viral genome replication (GO:0045071) | 3.34605982 |
109 | interferon-gamma production (GO:0032609) | 3.32899629 |
110 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.32733241 |
111 | regulation of interferon-alpha production (GO:0032647) | 3.31729975 |
112 | macrophage activation involved in immune response (GO:0002281) | 3.31521096 |
113 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.30614078 |
114 | positive regulation of defense response to virus by host (GO:0002230) | 3.29605890 |
115 | * regulation of interleukin-12 production (GO:0032655) | 3.28189173 |
116 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.28042005 |
117 | detection of bacterium (GO:0016045) | 3.26266193 |
118 | positive regulation of protein homooligomerization (GO:0032464) | 3.25548923 |
119 | T cell activation involved in immune response (GO:0002286) | 3.25100260 |
120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.24630591 |
121 | regulation of type 2 immune response (GO:0002828) | 3.24508047 |
122 | B cell receptor signaling pathway (GO:0050853) | 3.24179424 |
123 | sequestering of actin monomers (GO:0042989) | 3.22274139 |
124 | detection of other organism (GO:0098543) | 3.20969060 |
125 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.20183213 |
126 | positive regulation of T cell proliferation (GO:0042102) | 3.19960498 |
127 | regulation of interleukin-2 production (GO:0032663) | 3.19932832 |
128 | * regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19370985 |
129 | germinal center formation (GO:0002467) | 3.18742527 |
130 | regulation of alpha-beta T cell differentiation (GO:0046637) | 3.18721052 |
131 | B cell mediated immunity (GO:0019724) | 3.18474595 |
132 | alpha-beta T cell activation (GO:0046631) | 3.18007754 |
133 | * dendritic cell differentiation (GO:0097028) | 3.17603020 |
134 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.16921579 |
135 | regulation of response to interferon-gamma (GO:0060330) | 3.15742781 |
136 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.15596347 |
137 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.15596347 |
138 | regulation of alpha-beta T cell activation (GO:0046634) | 3.14119511 |
139 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.12469487 |
140 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.12469487 |
141 | regulation of necroptotic process (GO:0060544) | 3.11874571 |
142 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.11742093 |
143 | cellular response to interferon-gamma (GO:0071346) | 3.10189475 |
144 | negative regulation of type 2 immune response (GO:0002829) | 3.08813228 |
145 | negative regulation of innate immune response (GO:0045824) | 3.07057379 |
146 | positive T cell selection (GO:0043368) | 3.06551173 |
147 | positive regulation of B cell mediated immunity (GO:0002714) | 3.04141248 |
148 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.04141248 |
149 | response to peptidoglycan (GO:0032494) | 3.04140228 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.72217762 |
2 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.24967739 |
3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.75347270 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.63598107 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.55269604 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.80524752 |
7 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.71714548 |
8 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.42492392 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.37462515 |
10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.34553549 |
11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.23812343 |
12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.06707367 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.96207183 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85829587 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76102486 |
16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.72856868 |
17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.61628730 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.59538147 |
19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.57192585 |
20 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.56329823 |
21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.54321072 |
22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.44190685 |
23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29136309 |
24 | * MYB_26560356_Chip-Seq_TH1_Human | 2.19944480 |
25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16758702 |
26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04331324 |
27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92475255 |
28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.82227525 |
29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77845032 |
30 | MYC_22102868_ChIP-Seq_BL_Human | 1.77546770 |
31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.69368638 |
32 | MAF_26560356_Chip-Seq_TH2_Human | 1.66387635 |
33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.66270961 |
34 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65851764 |
35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65198959 |
36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60279815 |
37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.58317024 |
38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57015345 |
39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.52500099 |
40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51347287 |
41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45157684 |
42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45043829 |
43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.42431257 |
44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42398336 |
45 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41715570 |
46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41521354 |
47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41352542 |
48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38097609 |
49 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.38041137 |
50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37431625 |
51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36277512 |
52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32233460 |
53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30930152 |
54 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28858889 |
55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27684710 |
56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22332387 |
57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21485134 |
58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18661815 |
59 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16603279 |
60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13447152 |
61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09529669 |
62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08757729 |
63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08609237 |
64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07344360 |
65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05621596 |
66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01370049 |
67 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99980065 |
68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98689030 |
69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98190051 |
70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96288378 |
71 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95117042 |
72 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94588178 |
73 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94473651 |
74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94029984 |
75 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93113007 |
76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92247728 |
77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91927990 |
78 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91592148 |
79 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89985951 |
80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88079899 |
81 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85989203 |
82 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85152775 |
83 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.83410554 |
84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81508052 |
85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80617270 |
86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79262944 |
87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79182572 |
88 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77024504 |
89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.75842312 |
90 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75321650 |
91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73522749 |
92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73367095 |
93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73008977 |
94 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.72245802 |
95 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71997553 |
96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.71960694 |
97 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.70406782 |
98 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69489038 |
99 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69393873 |
100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68975058 |
101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.67804996 |
102 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.67658676 |
103 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.66170182 |
104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65288912 |
105 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.63146238 |
106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57875544 |
107 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.57100640 |
108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.56640809 |
109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.56640809 |
110 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.55733169 |
111 | P300_27268052_Chip-Seq_Bcells_Human | 0.54800611 |
112 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.54130719 |
113 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.53479381 |
114 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.53161798 |
115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.52867384 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.62196320 |
2 | MP0000685_abnormal_immune_system | 4.85806711 |
3 | MP0002138_abnormal_hepatobiliary_system | 4.81874077 |
4 | MP0004510_myositis | 3.87460778 |
5 | MP0005387_immune_system_phenotype | 3.79112971 |
6 | MP0001790_abnormal_immune_system | 3.79112971 |
7 | MP0005671_abnormal_response_to | 3.66756396 |
8 | MP0009785_altered_susceptibility_to | 3.39813749 |
9 | MP0002166_altered_tumor_susceptibility | 3.32405049 |
10 | * MP0002148_abnormal_hypersensitivity_rea | 3.24858146 |
11 | * MP0001800_abnormal_humoral_immune | 3.03272079 |
12 | * MP0005000_abnormal_immune_tolerance | 3.02580907 |
13 | MP0003436_decreased_susceptibility_to | 2.93061738 |
14 | MP0002254_reproductive_system_inflammat | 2.91738642 |
15 | MP0003763_abnormal_thymus_physiology | 2.85705011 |
16 | MP0002006_tumorigenesis | 2.82216020 |
17 | * MP0002723_abnormal_immune_serum | 2.74887796 |
18 | * MP0002452_abnormal_antigen_presenting | 2.71625304 |
19 | MP0005025_abnormal_response_to | 2.63304475 |
20 | * MP0001819_abnormal_immune_cell | 2.55798777 |
21 | * MP0002420_abnormal_adaptive_immunity | 2.52481426 |
22 | MP0002419_abnormal_innate_immunity | 2.19812671 |
23 | * MP0002398_abnormal_bone_marrow | 2.17640069 |
24 | * MP0000716_abnormal_immune_system | 2.12300408 |
25 | MP0002405_respiratory_system_inflammati | 2.03700820 |
26 | MP0002009_preneoplasia | 2.02911689 |
27 | MP0001873_stomach_inflammation | 1.98250602 |
28 | MP0006082_CNS_inflammation | 1.96543222 |
29 | MP0001853_heart_inflammation | 1.95492219 |
30 | * MP0005310_abnormal_salivary_gland | 1.91029238 |
31 | * MP0001348_abnormal_lacrimal_gland | 1.86230853 |
32 | MP0010155_abnormal_intestine_physiology | 1.78576777 |
33 | MP0004947_skin_inflammation | 1.78002937 |
34 | MP0003303_peritoneal_inflammation | 1.68754088 |
35 | MP0005451_abnormal_body_composition | 1.67249934 |
36 | MP0008057_abnormal_DNA_replication | 1.65858746 |
37 | MP0009333_abnormal_splenocyte_physiolog | 1.65256044 |
38 | * MP0002429_abnormal_blood_cell | 1.64811085 |
39 | * MP0002722_abnormal_immune_system | 1.57019381 |
40 | * MP0001845_abnormal_inflammatory_respons | 1.56296863 |
41 | MP0002277_abnormal_respiratory_mucosa | 1.56063071 |
42 | * MP0000689_abnormal_spleen_morphology | 1.49733453 |
43 | MP0003724_increased_susceptibility_to | 1.48053010 |
44 | * MP0000703_abnormal_thymus_morphology | 1.33784981 |
45 | MP0008469_abnormal_protein_level | 1.29965215 |
46 | MP0000569_abnormal_digit_pigmentation | 1.29187488 |
47 | MP0003448_altered_tumor_morphology | 1.25596971 |
48 | MP0002877_abnormal_melanocyte_morpholog | 1.21204842 |
49 | MP0009764_decreased_sensitivity_to | 1.20729703 |
50 | MP0005464_abnormal_platelet_physiology | 1.20122288 |
51 | MP0002396_abnormal_hematopoietic_system | 1.19148237 |
52 | * MP0002163_abnormal_gland_morphology | 1.15837473 |
53 | MP0001533_abnormal_skeleton_physiology | 1.15059504 |
54 | MP0004381_abnormal_hair_follicle | 1.14282035 |
55 | MP0005076_abnormal_cell_differentiation | 1.12763182 |
56 | MP0003866_abnormal_defecation | 1.10160409 |
57 | MP0000858_altered_metastatic_potential | 1.07588941 |
58 | MP0000465_gastrointestinal_hemorrhage | 1.06211372 |
59 | MP0001545_abnormal_hematopoietic_system | 1.06170224 |
60 | MP0005397_hematopoietic_system_phenotyp | 1.06170224 |
61 | MP0003300_gastrointestinal_ulcer | 1.05697740 |
62 | MP0010352_gastrointestinal_tract_polyps | 1.00985641 |
63 | MP0004808_abnormal_hematopoietic_stem | 0.98374589 |
64 | MP0003453_abnormal_keratinocyte_physiol | 0.93761611 |
65 | MP0002933_joint_inflammation | 0.92656244 |
66 | MP0003191_abnormal_cellular_cholesterol | 0.92403436 |
67 | MP0009840_abnormal_foam_cell | 0.89785785 |
68 | MP0003075_altered_response_to | 0.87313747 |
69 | MP0005075_abnormal_melanosome_morpholog | 0.82909099 |
70 | MP0001881_abnormal_mammary_gland | 0.80486245 |
71 | MP0002876_abnormal_thyroid_physiology | 0.78526418 |
72 | MP0005166_decreased_susceptibility_to | 0.77646167 |
73 | MP0008004_abnormal_stomach_pH | 0.76961061 |
74 | MP0001851_eye_inflammation | 0.75701060 |
75 | MP0002998_abnormal_bone_remodeling | 0.75604994 |
76 | MP0003690_abnormal_glial_cell | 0.73126843 |
77 | MP0008260_abnormal_autophagy | 0.72660448 |
78 | MP0009763_increased_sensitivity_to | 0.72430696 |
79 | * MP0003091_abnormal_cell_migration | 0.69531286 |
80 | MP0000343_altered_response_to | 0.69037061 |
81 | MP0002019_abnormal_tumor_incidence | 0.67718434 |
82 | MP0003183_abnormal_peptide_metabolism | 0.66471078 |
83 | MP0005174_abnormal_tail_pigmentation | 0.66151800 |
84 | MP0000627_abnormal_mammary_gland | 0.65882906 |
85 | MP0008874_decreased_physiological_sensi | 0.63719349 |
86 | MP0002332_abnormal_exercise_endurance | 0.63376694 |
87 | MP0002693_abnormal_pancreas_physiology | 0.63058073 |
88 | MP0000604_amyloidosis | 0.59662073 |
89 | MP0010307_abnormal_tumor_latency | 0.59577190 |
90 | MP0009278_abnormal_bone_marrow | 0.58705918 |
91 | MP0000249_abnormal_blood_vessel | 0.57510176 |
92 | MP0000490_abnormal_crypts_of | 0.56691555 |
93 | MP0005167_abnormal_blood-brain_barrier | 0.56660434 |
94 | MP0009765_abnormal_xenobiotic_induced | 0.55635639 |
95 | MP0002132_abnormal_respiratory_system | 0.55369849 |
96 | MP0002928_abnormal_bile_duct | 0.54529198 |
97 | MP0002136_abnormal_kidney_physiology | 0.53922331 |
98 | MP0003795_abnormal_bone_structure | 0.53246492 |
99 | MP0005058_abnormal_lysosome_morphology | 0.53221825 |
100 | MP0004883_abnormal_blood_vessel | 0.53129669 |
101 | MP0003045_fibrosis | 0.52589871 |
102 | MP0003806_abnormal_nucleotide_metabolis | 0.51742495 |
103 | MP0003656_abnormal_erythrocyte_physiolo | 0.51432393 |
104 | MP0008961_abnormal_basal_metabolism | 0.50424769 |
105 | MP0000371_diluted_coat_color | 0.49155774 |
106 | * MP0001346_abnormal_lacrimal_gland | 0.49152964 |
107 | MP0005381_digestive/alimentary_phenotyp | 0.49095945 |
108 | MP0002139_abnormal_hepatobiliary_system | 0.47316508 |
109 | MP0003566_abnormal_cell_adhesion | 0.46451298 |
110 | MP0003172_abnormal_lysosome_physiology | 0.46237548 |
111 | MP0003646_muscle_fatigue | 0.45694174 |
112 | MP0005623_abnormal_meninges_morphology | 0.45436516 |
113 | MP0005164_abnormal_response_to | 0.45237779 |
114 | MP0000767_abnormal_smooth_muscle | 0.44127095 |
115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.43872179 |
116 | MP0001243_abnormal_dermal_layer | 0.43482752 |
117 | MP0000609_abnormal_liver_physiology | 0.43337597 |
118 | MP0005390_skeleton_phenotype | 0.43020460 |
119 | MP0001663_abnormal_digestive_system | 0.36845837 |
120 | MP0001216_abnormal_epidermal_layer | 0.36436131 |
121 | MP0003943_abnormal_hepatobiliary_system | 0.35545498 |
122 | MP0000313_abnormal_cell_death | 0.35227893 |
123 | MP0009115_abnormal_fat_cell | 0.34794331 |
124 | MP0004782_abnormal_surfactant_physiolog | 0.34705234 |
125 | MP0000367_abnormal_coat/_hair | 0.33536312 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased IgM level (HP:0003496) | 6.98294470 |
2 | Chronic otitis media (HP:0000389) | 5.37394456 |
3 | Autoimmune thrombocytopenia (HP:0001973) | 5.24717664 |
4 | Eczematoid dermatitis (HP:0000976) | 5.24058004 |
5 | Abnormality of T cell number (HP:0011839) | 5.17372694 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.17350944 |
7 | Recurrent fungal infections (HP:0002841) | 5.08395202 |
8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.91201583 |
9 | Gastrointestinal infarctions (HP:0005244) | 4.80232922 |
10 | Recurrent viral infections (HP:0004429) | 4.79637699 |
11 | Optic neuritis (HP:0100653) | 4.68496302 |
12 | Retrobulbar optic neuritis (HP:0100654) | 4.68496302 |
13 | Myositis (HP:0100614) | 4.58064777 |
14 | Nasal polyposis (HP:0100582) | 4.35955743 |
15 | Recurrent bacterial skin infections (HP:0005406) | 4.33234685 |
16 | Orchitis (HP:0100796) | 4.31922184 |
17 | Vasculitis (HP:0002633) | 4.25974076 |
18 | Recurrent abscess formation (HP:0002722) | 4.23382757 |
19 | T lymphocytopenia (HP:0005403) | 4.18876266 |
20 | Hypergammaglobulinemia (HP:0010702) | 4.16912788 |
21 | Recurrent bronchitis (HP:0002837) | 4.12369021 |
22 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.09724651 |
23 | Recurrent cutaneous fungal infections (HP:0011370) | 4.09724651 |
24 | Eosinophilia (HP:0001880) | 4.08848948 |
25 | Autoimmune hemolytic anemia (HP:0001890) | 3.87451539 |
26 | Mediastinal lymphadenopathy (HP:0100721) | 3.85657154 |
27 | Abnormality of T cells (HP:0002843) | 3.74488231 |
28 | Agammaglobulinemia (HP:0004432) | 3.65837528 |
29 | Pulmonary infiltrates (HP:0002113) | 3.63869870 |
30 | Abnormality of the nasal mucosa (HP:0000433) | 3.63099563 |
31 | Granulocytopenia (HP:0001913) | 3.61878763 |
32 | Abnormality of eosinophils (HP:0001879) | 3.60893645 |
33 | Recurrent skin infections (HP:0001581) | 3.55546442 |
34 | Leukocytosis (HP:0001974) | 3.46293094 |
35 | IgG deficiency (HP:0004315) | 3.37286753 |
36 | Panhypogammaglobulinemia (HP:0003139) | 3.35268931 |
37 | Abnormality of the fingertips (HP:0001211) | 3.33224609 |
38 | Thrombocytosis (HP:0001894) | 3.30972287 |
39 | Arterial thrombosis (HP:0004420) | 3.26028886 |
40 | Abnormality of macrophages (HP:0004311) | 3.24179883 |
41 | Chronic sinusitis (HP:0011109) | 3.23857888 |
42 | Abnormality of T cell physiology (HP:0011840) | 3.23181409 |
43 | Increased IgE level (HP:0003212) | 3.23007277 |
44 | Fatigue (HP:0012378) | 3.13368544 |
45 | Chronic diarrhea (HP:0002028) | 3.10777624 |
46 | Joint swelling (HP:0001386) | 3.07336807 |
47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.05678003 |
48 | Hypochromic anemia (HP:0001931) | 3.05388989 |
49 | IgM deficiency (HP:0002850) | 3.04895305 |
50 | Hemoptysis (HP:0002105) | 3.04461116 |
51 | Severe combined immunodeficiency (HP:0004430) | 3.03773878 |
52 | Meningitis (HP:0001287) | 2.94032022 |
53 | Basal ganglia calcification (HP:0002135) | 2.84110880 |
54 | Stomatitis (HP:0010280) | 2.83253951 |
55 | Combined immunodeficiency (HP:0005387) | 2.82025544 |
56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.81185696 |
57 | Abnormality of B cell number (HP:0010975) | 2.80242365 |
58 | Keratoconjunctivitis sicca (HP:0001097) | 2.79601117 |
59 | Encephalitis (HP:0002383) | 2.79076707 |
60 | Colitis (HP:0002583) | 2.76599712 |
61 | IgA deficiency (HP:0002720) | 2.75346356 |
62 | Inflammation of the large intestine (HP:0002037) | 2.75050816 |
63 | Gingival bleeding (HP:0000225) | 2.71376709 |
64 | Periodontitis (HP:0000704) | 2.70696569 |
65 | Lymphopenia (HP:0001888) | 2.67915721 |
66 | Thyroiditis (HP:0100646) | 2.67604031 |
67 | Chest pain (HP:0100749) | 2.65014953 |
68 | Gastrointestinal inflammation (HP:0004386) | 2.61140136 |
69 | Cellulitis (HP:0100658) | 2.61129650 |
70 | Keratoconjunctivitis (HP:0001096) | 2.60453687 |
71 | B lymphocytopenia (HP:0010976) | 2.59527333 |
72 | Abnormality of the pleura (HP:0002103) | 2.53842444 |
73 | Gingivitis (HP:0000230) | 2.53086342 |
74 | Myocardial infarction (HP:0001658) | 2.50956095 |
75 | Porencephaly (HP:0002132) | 2.47704375 |
76 | Amaurosis fugax (HP:0100576) | 2.45735449 |
77 | Lymphoma (HP:0002665) | 2.45387262 |
78 | Restrictive lung disease (HP:0002091) | 2.44990739 |
79 | Pustule (HP:0200039) | 2.44208351 |
80 | Obstructive lung disease (HP:0006536) | 2.40523221 |
81 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40523221 |
82 | Tetraparesis (HP:0002273) | 2.37946458 |
83 | Hypertensive crisis (HP:0100735) | 2.34326961 |
84 | Pulmonary embolism (HP:0002204) | 2.32619985 |
85 | Emphysema (HP:0002097) | 2.31506356 |
86 | Interstitial pulmonary disease (HP:0006530) | 2.31314827 |
87 | Anorexia (HP:0002039) | 2.29664201 |
88 | Spontaneous hematomas (HP:0007420) | 2.28781713 |
89 | Neutropenia (HP:0001875) | 2.26017278 |
90 | Loss of speech (HP:0002371) | 2.24261933 |
91 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23859076 |
92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23859076 |
93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23859076 |
94 | Bronchitis (HP:0012387) | 2.23767086 |
95 | Polyneuropathy (HP:0001271) | 2.21445976 |
96 | Peritonitis (HP:0002586) | 2.18787163 |
97 | Papilloma (HP:0012740) | 2.18300417 |
98 | Verrucae (HP:0200043) | 2.18300417 |
99 | Anhidrosis (HP:0000970) | 2.16706810 |
100 | Sepsis (HP:0100806) | 2.13126829 |
101 | Keratitis (HP:0000491) | 2.10639098 |
102 | Urticaria (HP:0001025) | 2.10204331 |
103 | Arthralgia (HP:0002829) | 2.08706668 |
104 | Glomerulopathy (HP:0100820) | 2.08131369 |
105 | Premature loss of primary teeth (HP:0006323) | 2.04574141 |
106 | Gangrene (HP:0100758) | 2.04539448 |
107 | Cerebral ischemia (HP:0002637) | 2.04161421 |
108 | Gastrointestinal stroma tumor (HP:0100723) | 2.03622329 |
109 | Abnormality of the prostate (HP:0008775) | 2.03578171 |
110 | Skin ulcer (HP:0200042) | 2.03547829 |
111 | Polycythemia (HP:0001901) | 2.03113946 |
112 | Abnormality of the endocardium (HP:0004306) | 1.99843574 |
113 | Acute hepatic failure (HP:0006554) | 1.99371760 |
114 | Osteolytic defects of the hand bones (HP:0009699) | 1.98435299 |
115 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98435299 |
116 | Recurrent pneumonia (HP:0006532) | 1.97731469 |
117 | Recurrent sinusitis (HP:0011108) | 1.97374803 |
118 | Viral hepatitis (HP:0006562) | 1.97091817 |
119 | Hematochezia (HP:0002573) | 1.96388414 |
120 | Osteomyelitis (HP:0002754) | 1.94127188 |
121 | Petechiae (HP:0000967) | 1.93554064 |
122 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93489445 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 6.03196496 |
2 | TYK2 | 4.23002388 |
3 | JAK3 | 3.90400354 |
4 | MAP3K13 | 3.72779494 |
5 | IKBKB | 3.65774509 |
6 | IKBKE | 3.35606384 |
7 | TBK1 | 3.32665806 |
8 | PRPF4B | 3.13443809 |
9 | MAP4K1 | 3.07232473 |
10 | CHUK | 2.93128296 |
11 | JAK1 | 2.84892621 |
12 | FGFR4 | 2.70004520 |
13 | EPHB1 | 2.26152583 |
14 | IRAK4 | 2.25458555 |
15 | TXK | 2.22732894 |
16 | EPHA3 | 1.96711287 |
17 | PASK | 1.92854214 |
18 | FGFR3 | 1.75782394 |
19 | PIM2 | 1.71833785 |
20 | ZAP70 | 1.70254545 |
21 | NLK | 1.69461958 |
22 | BLK | 1.61627799 |
23 | SYK | 1.53023796 |
24 | KIT | 1.52471259 |
25 | GRK7 | 1.49154223 |
26 | MST4 | 1.44014386 |
27 | BCR | 1.43136820 |
28 | ERN1 | 1.42174013 |
29 | TAOK2 | 1.40208544 |
30 | MATK | 1.34707434 |
31 | PIM1 | 1.33017785 |
32 | RIPK4 | 1.26088271 |
33 | LCK | 1.24434126 |
34 | GRK6 | 1.24410013 |
35 | BTK | 1.22427403 |
36 | BMPR2 | 1.20307973 |
37 | PKN1 | 1.17062064 |
38 | ITK | 1.16499996 |
39 | CSK | 1.15425875 |
40 | JAK2 | 1.13645732 |
41 | TNK2 | 1.13550654 |
42 | FLT3 | 1.11573976 |
43 | CSF1R | 1.05973257 |
44 | HCK | 1.05972920 |
45 | CAMKK1 | 1.03843496 |
46 | TEC | 1.03047171 |
47 | SMG1 | 0.99385866 |
48 | RPS6KA4 | 0.98624024 |
49 | SIK3 | 0.98416482 |
50 | PRKCQ | 0.97022951 |
51 | MAP3K11 | 0.95840392 |
52 | IRAK1 | 0.94652185 |
53 | STK10 | 0.93358036 |
54 | ARAF | 0.90941894 |
55 | CDC42BPA | 0.90119380 |
56 | TAOK1 | 0.89108967 |
57 | IRAK3 | 0.87256442 |
58 | NEK9 | 0.81293218 |
59 | TAOK3 | 0.80753276 |
60 | LRRK2 | 0.79442954 |
61 | SIK2 | 0.77847325 |
62 | MAP3K10 | 0.76999153 |
63 | MAP3K3 | 0.75714658 |
64 | STK4 | 0.75633609 |
65 | STK24 | 0.75519487 |
66 | CAMKK2 | 0.71344400 |
67 | CLK1 | 0.71318732 |
68 | PTK6 | 0.69011930 |
69 | CDK12 | 0.67520937 |
70 | MAPKAPK2 | 0.66332376 |
71 | RIPK1 | 0.65600610 |
72 | TESK1 | 0.65039668 |
73 | EIF2AK2 | 0.64180953 |
74 | RPS6KA5 | 0.64154345 |
75 | TYRO3 | 0.62575450 |
76 | LYN | 0.62259404 |
77 | PDK1 | 0.61246306 |
78 | MAPK7 | 0.51067558 |
79 | TGFBR2 | 0.50851870 |
80 | PRKAA2 | 0.48406319 |
81 | PRKCD | 0.48121400 |
82 | MARK3 | 0.48038896 |
83 | RPS6KA1 | 0.46647878 |
84 | NME2 | 0.46248475 |
85 | MAP2K6 | 0.45636034 |
86 | MELK | 0.43623220 |
87 | ADRBK2 | 0.43591190 |
88 | MAP3K5 | 0.41330475 |
89 | TESK2 | 0.40623918 |
90 | RAF1 | 0.40430056 |
91 | RET | 0.40218626 |
92 | ABL1 | 0.39601692 |
93 | FYN | 0.37080303 |
94 | BMX | 0.36055845 |
95 | EGFR | 0.34655740 |
96 | MAPK12 | 0.34611610 |
97 | MAPK4 | 0.34043789 |
98 | KDR | 0.33548072 |
99 | FES | 0.33394385 |
100 | DDR2 | 0.32988321 |
101 | HIPK2 | 0.32872977 |
102 | IRAK2 | 0.31680738 |
103 | TRIB3 | 0.31494711 |
104 | MAP3K1 | 0.31322758 |
105 | ALK | 0.29548669 |
106 | NUAK1 | 0.29351210 |
107 | MARK2 | 0.29209393 |
108 | ACVR1B | 0.29138682 |
109 | BRD4 | 0.26448865 |
110 | SIK1 | 0.23994912 |
111 | MAP2K3 | 0.23976107 |
112 | MAP2K2 | 0.22596449 |
113 | PDPK1 | 0.22429660 |
114 | INSR | 0.21730290 |
115 | DMPK | 0.21622058 |
116 | TLK1 | 0.21048700 |
117 | MOS | 0.20388651 |
118 | MAP3K7 | 0.19906376 |
119 | MAP3K8 | 0.19681463 |
120 | MAP3K9 | 0.19620674 |
121 | DYRK1B | 0.19370873 |
122 | WNK1 | 0.16210473 |
123 | TRPM7 | 0.15934294 |
124 | AKT1 | 0.15266555 |
125 | ABL2 | 0.15222724 |
126 | CDK6 | 0.14336924 |
127 | CDK4 | 0.13642239 |
128 | RPS6KA6 | 0.13398672 |
129 | MAPK3 | 0.13373068 |
130 | PDGFRB | 0.12850988 |
131 | STK3 | 0.12634111 |
132 | FGR | 0.12573647 |
133 | CDK9 | 0.12240633 |
134 | MAPK11 | 0.12023664 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 4.64289861 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.74106064 |
3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.39631827 |
4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.12836929 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.11596965 |
6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.92632428 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92095168 |
8 | Measles_Homo sapiens_hsa05162 | 2.76959197 |
9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.62732163 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48076829 |
11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.38115564 |
12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.33980181 |
13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31610782 |
14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.18737862 |
15 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.00143174 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99062701 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.97519226 |
18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93894133 |
19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.92801322 |
20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92094914 |
21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.90065847 |
22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89390120 |
23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.88379304 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.83424434 |
25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70918466 |
26 | Apoptosis_Homo sapiens_hsa04210 | 1.65802205 |
27 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54602143 |
28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47066487 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.42571331 |
30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.34870639 |
31 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33347159 |
32 | Shigellosis_Homo sapiens_hsa05131 | 1.29667931 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27326428 |
34 | Hepatitis B_Homo sapiens_hsa05161 | 1.27108311 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.21516529 |
36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21139302 |
37 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.20539369 |
38 | Tuberculosis_Homo sapiens_hsa05152 | 1.17708808 |
39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12371615 |
40 | Hepatitis C_Homo sapiens_hsa05160 | 1.07330481 |
41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03977410 |
42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03764882 |
43 | Asthma_Homo sapiens_hsa05310 | 1.02749297 |
44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99258940 |
45 | Malaria_Homo sapiens_hsa05144 | 0.99015595 |
46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88243389 |
47 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85402633 |
48 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83183571 |
49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81696965 |
50 | Salmonella infection_Homo sapiens_hsa05132 | 0.80408404 |
51 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.79358348 |
52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76588615 |
53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73307960 |
54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71483580 |
55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70971507 |
56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67741020 |
57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66509031 |
58 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65706168 |
59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65494140 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65254052 |
61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63746346 |
62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63482875 |
63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59340449 |
64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58796086 |
65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56194242 |
66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45260686 |
67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44607347 |
68 | Platelet activation_Homo sapiens_hsa04611 | 0.42599875 |
69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41594917 |
70 | Proteasome_Homo sapiens_hsa03050 | 0.39969400 |
71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36440528 |
72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35499720 |
73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34794527 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.31648312 |
75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31296327 |
76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30413469 |
77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30260348 |
78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30175451 |
79 | Prostate cancer_Homo sapiens_hsa05215 | 0.28518755 |
80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26534919 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25839758 |
82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25722473 |
83 | Amoebiasis_Homo sapiens_hsa05146 | 0.25657418 |
84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25312344 |
85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24191314 |
86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21994833 |
87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21283595 |
88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21163918 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20034669 |
90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19081583 |
91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18817808 |
92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.18383322 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.17916585 |
94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17342954 |
95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16826805 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.16091418 |
97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.15831771 |
98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15306676 |
99 | Phagosome_Homo sapiens_hsa04145 | 0.14728431 |
100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13335077 |
101 | Prion diseases_Homo sapiens_hsa05020 | 0.13334454 |
102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.12893960 |
103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.12363388 |
104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12329732 |
105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.11340822 |
106 | Lysosome_Homo sapiens_hsa04142 | 0.09672270 |
107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.09647882 |
108 | Adherens junction_Homo sapiens_hsa04520 | 0.09585309 |
109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.08491549 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.08049529 |
111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.07747350 |
112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.07518008 |
113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.07254654 |
114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.05500340 |
115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.05086926 |
116 | Bladder cancer_Homo sapiens_hsa05219 | 0.04146166 |